Robert M Schwarcz, MD

Robert M Schwarcz, MD
135 E 71st St Ste 1A
New York,, NY
USA 10021
Papers:
Treatment of Moderate-to-Severe Glabellar Lines with Relabotulinumtoxina, a New Liquid Botulinum Toxin: Clinical Efficacy and Safety Results from the Ready-1 Phase III Trial